Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-07

Clinical Trial Update: Assessment of The Effect of Apixaban in AF

View source ↗

Summary

This clinical trial update notes that the apixaban study in atrial fibrillation has completed. It lists atrial fibrillation and thromboembolism as conditions st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eliquis (apixaban)

Snippet

Sponsor: East and North Hertfordshire NHS Trust | Conditions: Atrial Fibrillation, Embolism Thrombosis | Status: COMPLETED